Logo image of TFX

TELEFLEX INC (TFX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TFX - US8793691069 - Common Stock

122.4 USD
+0.36 (+0.29%)
Last: 1/2/2026, 8:04:00 PM
122.4 USD
0 (0%)
After Hours: 1/2/2026, 8:04:00 PM
Fundamental Rating

5

Overall TFX gets a fundamental rating of 5 out of 10. We evaluated TFX against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of TFX get a neutral evaluation. Nothing too spectacular is happening here. TFX may be a bit undervalued, certainly considering the very reasonable score on growth This makes TFX very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year TFX was profitable.
TFX had a positive operating cash flow in the past year.
In the past 5 years TFX has always been profitable.
TFX had a positive operating cash flow in each of the past 5 years.
TFX Yearly Net Income VS EBIT VS OCF VS FCFTFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.17%, TFX is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
TFX has a better Return On Equity (-8.58%) than 68.82% of its industry peers.
The Return On Invested Capital of TFX (6.93%) is better than 81.72% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TFX is in line with the industry average of 8.84%.
Industry RankSector Rank
ROA -4.17%
ROE -8.58%
ROIC 6.93%
ROA(3y)3.65%
ROA(5y)4.54%
ROE(3y)6.23%
ROE(5y)8.33%
ROIC(3y)7.21%
ROIC(5y)7.23%
TFX Yearly ROA, ROE, ROICTFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

TFX's Profit Margin has declined in the last couple of years.
The Operating Margin of TFX (17.59%) is better than 89.25% of its industry peers.
TFX's Operating Margin has been stable in the last couple of years.
TFX's Gross Margin of 53.67% is in line compared to the rest of the industry. TFX outperforms 49.46% of its industry peers.
In the last couple of years the Gross Margin of TFX has remained more or less at the same level.
Industry RankSector Rank
OM 17.59%
PM (TTM) N/A
GM 53.67%
OM growth 3Y-3.43%
OM growth 5Y0.95%
PM growth 3Y-49.04%
PM growth 5Y-33.65%
GM growth 3Y0.43%
GM growth 5Y-0.56%
TFX Yearly Profit, Operating, Gross MarginsTFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TFX is destroying value.
The number of shares outstanding for TFX has been reduced compared to 1 year ago.
Compared to 5 years ago, TFX has less shares outstanding
Compared to 1 year ago, TFX has an improved debt to assets ratio.
TFX Yearly Shares OutstandingTFX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TFX Yearly Total Debt VS Total AssetsTFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.31 indicates that TFX is not a great score, but indicates only limited risk for bankruptcy at the moment.
TFX's Altman-Z score of 2.31 is fine compared to the rest of the industry. TFX outperforms 65.59% of its industry peers.
The Debt to FCF ratio of TFX is 10.11, which is on the high side as it means it would take TFX, 10.11 years of fcf income to pay off all of its debts.
TFX's Debt to FCF ratio of 10.11 is fine compared to the rest of the industry. TFX outperforms 72.58% of its industry peers.
TFX has a Debt/Equity ratio of 0.67. This is a neutral value indicating TFX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.67, TFX is not doing good in the industry: 65.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 10.11
Altman-Z 2.31
ROIC/WACC0.69
WACC10.05%
TFX Yearly LT Debt VS Equity VS FCFTFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.57 indicates that TFX has no problem at all paying its short term obligations.
With a Current ratio value of 2.57, TFX perfoms like the industry average, outperforming 53.76% of the companies in the same industry.
TFX has a Quick Ratio of 1.53. This is a normal value and indicates that TFX is financially healthy and should not expect problems in meeting its short term obligations.
TFX has a Quick ratio (1.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.53
TFX Yearly Current Assets VS Current LiabilitesTFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.19% over the past year.
The Earnings Per Share has been growing slightly by 4.67% on average over the past years.
The Revenue has been growing slightly by 5.43% in the past year.
TFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.26% yearly.
EPS 1Y (TTM)5.19%
EPS 3Y1.67%
EPS 5Y4.67%
EPS Q2Q%5.16%
Revenue 1Y (TTM)5.43%
Revenue growth 3Y2.74%
Revenue growth 5Y3.26%
Sales Q2Q%19.45%

3.2 Future

TFX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.35% yearly.
Based on estimates for the next years, TFX will show a small growth in Revenue. The Revenue will grow by 6.90% on average per year.
EPS Next Y1.67%
EPS Next 2Y4.2%
EPS Next 3Y4.48%
EPS Next 5Y6.35%
Revenue Next Year7.68%
Revenue Next 2Y9.09%
Revenue Next 3Y7.44%
Revenue Next 5Y6.9%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TFX Yearly Revenue VS EstimatesTFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
TFX Yearly EPS VS EstimatesTFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15 20

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.62, the valuation of TFX can be described as very reasonable.
TFX's Price/Earnings ratio is rather cheap when compared to the industry. TFX is cheaper than 95.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of TFX to the average of the S&P500 Index (26.60), we can say TFX is valued rather cheaply.
TFX is valuated reasonably with a Price/Forward Earnings ratio of 8.05.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TFX indicates a rather cheap valuation: TFX is cheaper than 97.31% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.23. TFX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.62
Fwd PE 8.05
TFX Price Earnings VS Forward Price EarningsTFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TFX indicates a rather cheap valuation: TFX is cheaper than 93.01% of the companies listed in the same industry.
88.17% of the companies in the same industry are more expensive than TFX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.46
EV/EBITDA 9.14
TFX Per share dataTFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TFX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TFX may justify a higher PE ratio.
PEG (NY)5.15
PEG (5Y)1.84
EPS Next 2Y4.2%
EPS Next 3Y4.48%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.11%, TFX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.20, TFX pays a better dividend. On top of this TFX pays more dividend than 94.62% of the companies listed in the same industry.
With a Dividend Yield of 1.11, TFX pays less dividend than the S&P500 average, which is at 1.93.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of TFX has a limited annual growth rate of 0.04%.
TFX has paid a dividend for at least 10 years, which is a reliable track record.
As TFX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.04%
Div Incr Years0
Div Non Decr Years6
TFX Yearly Dividends per shareTFX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of TFX are negative and hence is the payout ratio. TFX will probably not be able to sustain this dividend level.
The dividend of TFX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-18.59%
EPS Next 2Y4.2%
EPS Next 3Y4.48%
TFX Yearly Income VS Free CF VS DividendTFX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

TELEFLEX INC

NYSE:TFX (1/2/2026, 8:04:00 PM)

After market: 122.4 0 (0%)

122.4

+0.36 (+0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners108.18%
Inst Owner Change5.1%
Ins Owners0.3%
Ins Owner Change1.36%
Market Cap5.41B
Revenue(TTM)3.19B
Net Income(TTM)-327.97M
Analysts54.29
Price Target140.78 (15.02%)
Short Float %3.92%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend1.36
Dividend Growth(5Y)0.04%
DP-18.59%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.63%
Min EPS beat(2)7.42%
Max EPS beat(2)9.84%
EPS beat(4)2
Avg EPS beat(4)3.94%
Min EPS beat(4)-1.22%
Max EPS beat(4)9.84%
EPS beat(8)6
Avg EPS beat(8)3.15%
EPS beat(12)10
Avg EPS beat(12)3.75%
EPS beat(16)14
Avg EPS beat(16)3.38%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.62%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)1.26%
Revenue beat(8)3
Avg Revenue beat(8)-0.64%
Revenue beat(12)6
Avg Revenue beat(12)-0.2%
Revenue beat(16)8
Avg Revenue beat(16)-0.4%
PT rev (1m)3.33%
PT rev (3m)-1.27%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-5.93%
EPS NY rev (1m)0.5%
EPS NY rev (3m)0.5%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)-5.51%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 8.62
Fwd PE 8.05
P/S 1.7
P/FCF 20.46
P/OCF 13.84
P/B 1.42
P/tB N/A
EV/EBITDA 9.14
EPS(TTM)14.2
EY11.6%
EPS(NY)15.21
Fwd EY12.43%
FCF(TTM)5.98
FCFY4.89%
OCF(TTM)8.85
OCFY7.23%
SpS72.19
BVpS86.49
TBVpS-25.49
PEG (NY)5.15
PEG (5Y)1.84
Graham Number166.23
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -8.58%
ROCE 7.91%
ROIC 6.93%
ROICexc 7.3%
ROICexgc 27.39%
OM 17.59%
PM (TTM) N/A
GM 53.67%
FCFM 8.29%
ROA(3y)3.65%
ROA(5y)4.54%
ROE(3y)6.23%
ROE(5y)8.33%
ROIC(3y)7.21%
ROIC(5y)7.23%
ROICexc(3y)7.52%
ROICexc(5y)7.62%
ROICexgc(3y)37.85%
ROICexgc(5y)40.71%
ROCE(3y)8.23%
ROCE(5y)8.25%
ROICexgc growth 3Y-9.53%
ROICexgc growth 5Y0.44%
ROICexc growth 3Y-3.04%
ROICexc growth 5Y1.71%
OM growth 3Y-3.43%
OM growth 5Y0.95%
PM growth 3Y-49.04%
PM growth 5Y-33.65%
GM growth 3Y0.43%
GM growth 5Y-0.56%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 10.11
Debt/EBITDA 3.05
Cap/Depr 44.78%
Cap/Sales 3.97%
Interest Coverage 250
Cash Conversion 46.32%
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.53
Altman-Z 2.31
F-Score5
WACC10.05%
ROIC/WACC0.69
Cap/Depr(3y)39.38%
Cap/Depr(5y)37.65%
Cap/Sales(3y)3.35%
Cap/Sales(5y)3.24%
Profit Quality(3y)307.01%
Profit Quality(5y)228.72%
High Growth Momentum
Growth
EPS 1Y (TTM)5.19%
EPS 3Y1.67%
EPS 5Y4.67%
EPS Q2Q%5.16%
EPS Next Y1.67%
EPS Next 2Y4.2%
EPS Next 3Y4.48%
EPS Next 5Y6.35%
Revenue 1Y (TTM)5.43%
Revenue growth 3Y2.74%
Revenue growth 5Y3.26%
Sales Q2Q%19.45%
Revenue Next Year7.68%
Revenue Next 2Y9.09%
Revenue Next 3Y7.44%
Revenue Next 5Y6.9%
EBIT growth 1Y3.97%
EBIT growth 3Y-0.78%
EBIT growth 5Y4.24%
EBIT Next Year11.77%
EBIT Next 3Y7.77%
EBIT Next 5Y6.67%
FCF growth 1Y-30.38%
FCF growth 3Y-4.23%
FCF growth 5Y8.62%
OCF growth 1Y-16.82%
OCF growth 3Y-0.81%
OCF growth 5Y7.66%

TELEFLEX INC / TFX FAQ

What is the ChartMill fundamental rating of TELEFLEX INC (TFX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TFX.


What is the valuation status for TFX stock?

ChartMill assigns a valuation rating of 7 / 10 to TELEFLEX INC (TFX). This can be considered as Undervalued.


What is the profitability of TFX stock?

TELEFLEX INC (TFX) has a profitability rating of 6 / 10.


What is the valuation of TELEFLEX INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TELEFLEX INC (TFX) is 8.62 and the Price/Book (PB) ratio is 1.42.


How financially healthy is TELEFLEX INC?

The financial health rating of TELEFLEX INC (TFX) is 5 / 10.